TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study.

Carrie L Kitko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.